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Poly(A)‘RNA composition differences for normal, fetal and clrrhotlc human liver before and after retmolc acid-Induced differentiation of the F9 
embryonal carcinoma cell line were analyzed by a novel poly(A)‘RNA patterns method. The method IS based on the polyacrylamlde gel 
electrophoretic analysis of short cDNA termination products. synthesized by reverse transcrlptase usmg poly(A)+RNA as a template. a set of short 
S-end labeled primers, three natural and one termmator deoxyribonucleotide. A number of known dlfferentlally expressed genes and some unknown 
ones were then identified by direct sequencmg of the differentially represented bands excised from a gel and searching a complementary mRNA 
target sites in GenBank database 
Poly(A)‘RNA pattern; Reverse transcriptase: Differentially expressed genes; Fetal hver, Cirrhosis; F9 embryonal carcinoma 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The development of new methods that allow the de- 
tection and isolation of differentially expressed genes is 
important for studying gene regulation and differentia- 
tion. The approaches, using high resolution 2-dimen- 
sional gel protein analysis [l], differential screening of 
cDNA libraries [2,3] and differential analysis of mRNA 
composition by arbitrary primed PCR [4.5] are used. 
Recently, we have reported the description of a novel 
method for determination of the poly(A)‘RNA compo- 
sition of a given cell or tissue type [6,7]. The composi- 
tion of poly(A)‘RNA is revealed as electrophoretic pat- 
terns of short cDNA termination products. synthesized 
by reverse transcription of poly(A)‘RNA, primed with 
a short oligonucleotide. In this report we attempted to 
make a link from electrophoretic pattern data to the 
level of primary structure data for a number of differen- 
tially represented bands. To this end we analyzed the 
differences in the patterns of poly(A)‘RNAs from three 
different but still closely related tissues: normal. cir- 
rhotic and fetal livers and the changes of poly(A)‘RNA 
patterns during F9 cell differentiation. The direct chem- 
ical sequencing of specific bands excised from a gel then 
provide enough information to identify the differen- 
tially expressed genes, direct primer-extension sequenc- 
ing of poly(A)‘RNA [8], PCR amplification/cloning [4] 
and cloning of differentially expressed genes from a 
cDNA library using a hybridization approach, 
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2.1. Oligomrc,leotldeJ 
Fl(TGCAGGCTG), F’(TGCAGGTGG). F4(TGGAGCTGG). 
FS(TGTGGCTGG). F6(TGTGGCAGG). PQTGCTGGGGA), 
PlO(TGCTGGAGG), P32(TGCTGGAGT). P33(TGCTGGACG). 
P34(TGCTGGATG), P35(TGCTGGCGG), P36(TGCTGGTGG). 
P37(TGCTGCAGG), P38(TGCTGTAGG), P39(TGCTGGCGT), 
P40(TGCTGGCGC). P41(TGCTGGCAG), P42(TGCTGGCCG). 
P43(TGCTGACGG), P+I(TGCTGTCGG), P46(TGCTGGTGT). 
P47(TGCTGGTGC), P48(TGCTGGTAG). P49(TGCTGGTCG), 
PSO(TGCTGGCGA). PSl(TGCTGGTGA), P55(TGCTGGGTG), 
P56(TGCTGGTTG). P57(TGCTGGCTG), P59(TGCTGCATG) 
were synthesized on a 370A Applied Biosystems DNA synthesizer and 
labeled using [y-“P]ATP and T4 polynucleotlde kmase [9]. 
2 2. c,DNA synthesis 
Condltlons for cDNA synthesis by M-MLV reverse transcriptase 
m the presence of three natural nucleotides and one terminator nucle- 
otide (ddUTP(5AA-Fam)), subsequent treatment with snake venom 
phoshodlesterase and polyacrylamide-urea gel electrophoresls were 
previously described [4.5]. Ohgo d(T), was used as the Size marker. 
2.3. Poly(AI’RNA pur&atiorI 
All normal tissues, fetal liver (24-weeks foetus) and cirrhotic liver 
were obtained wlthm l-2 h of sudden death and characterized in 
accordance with [4]. The F9 embryonal carcinoma cells were grown 
and induced to differentiate by treatment with retmoic acid and dibu- 
tyryl CAMP as previously described [lo]. Poly(A)‘RNAs were purified 
from frozen tissue or cells and characterized as previously described 
[4,51. 
2.4 Chetmcul sequencing of oligonucleotides 
Bands were excised from the gel and oligonucleotldes were eiuted 
by Incubating each gel shce m 1 ml of deionized water contammg 5 
,&ml of total yeast RNA for 3 h at 55°C. Each solution was then 
loaded onto a DE52 cellulose column (5 ~1). and the ohgonucleotide 
was eluted in 20 ~1 of 1 M NaCI, desalted on a G15 sephadex column 
(200 ~1) equilibrated with deionized water, and dried under vacuum 
Cleavage at G residues with dimethylsulphate. G+A residues with 
piperidimum formate and T residues with potassmm permanganate 
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were carried out as described [ll]. The reaction on C residues was 
performed with hydrogen peroxide [12]. Prperidine strand cleavage 
was carried out for all reactions [ll]. Electrophoresis of the cleavage 
products was performed using 20% polyacrylamrde-urea gels. 
2.5. Searching for mRNA turget slles 
We have used Wisconsin University GCG computer program[l3] 
and the GenBank (release 70.0) database to identify sequences comple- 
mentary to the sequenced oligonucleotides. 
3. RESULTS AND DISCUSSION 
3.1. Comparison of normal, cirrhotic and fetal livers 
Previously, we showed that a set of 30 primers pro- 
vides 90-95% probability of initiating synthesis from 
any individual RNA present in the poly(A)+RNA. This 
provides a comprehensive analysis of all RNAs having 
abundances higher than 0.1% [4.5]. Of the 30 primers 
used, at least 28 showed clear reproducible quantitative 
or qualitative differences in the individual RNA pat- 
terns for normal and fetal liver poly(A)‘RNAs, but only 
5 primers produced different poly(A)‘RNA spectra for 
normal and cirrhotic livers. The data shown in Fig. 1 
demonstrate such differences in the poly(A)‘RNA spec- 
tra for normal and fetal livers (primer Fl, F6, P55, P41, 
PlO, P35, P36, P57), and for normal and cirrhotic livers 
(F6, bands 1, 2; P55, band 3; P35, band 4; P36, bands 
5,6; P57, band 7) with no such differences observed for 
Fig. 1. Comparison of poly(A)‘RNA patterns for normal (N), cir- 
rhotic (C) and fetal (F) human livers using prtmers, Fl, F6, P55. P41, 
PlO, P35. P36, P57. P32. 
primer P32. All differentially represented bands (Fig. 1) 
did not show individual-specific differences although six 
primers out of 30 primers tested revealed individual- 
specific differences (about 0.2% of the total number of 
bands in the poly(A)‘RNA pattern) (data not shown). 
To prove that the observed differences in the 
poly(A)‘RNA spectra reflect differences in the 
poly(A)‘RNA composition we isolated and sequenced 
several arbitrarily chosen bands 8-18. Table IA shows 
the sequences of these bands and the results of searching 
for possible complementary sequences in the GenBank 
database. Out of 11 sequences analyzed, 2 sequences 
(bands 14 and 15) did not correspond to any sequence 
deposited in the GenBank database. For the remaining 
7 sequences (bands 9. 10, 11, 12. 13. 17, 18). a unique 
complementary sequence was found. One sequence 
(band 16) corresponded to two target individual 
mRNAs and there were a number of mRNAs (6 human 
genes) which possessed a complementary target site for 
the sequence of band 8. In accordance with data shown 
in Table 1A and Fig. 1, al -globin, a2-globin, A,-globin, 
G,-globin and insulin-like growth factor mRNAs ap- 
parently exhibit enhanced expression in fetal liver com- 
pared with normal liver. This is in accordance with 
numerous data concerning enhanced expression of these 
genes during fetal development [ 14,151. Mismatch anal- 
ysis shows that the allowed mismatches are located 
within the first four nucleotides at the 5’-end of the 
primer (Table 1). 
3.2. Differelltiation of F9 embryonal carcinoma cells 
F9 embryonal carcinoma cells (derived from a mouse 
testicular teratocarcinoma) can be induced to differenti- 
ate to parietal endodermic cells by treatment with reti- 
noic acid and dibutyryl CAMP [lo]. Changes in the cel- 
lular phenotype, which occur in vitro after 2-3 days of 
such treatment, are well defined by coordinate changes 
in the expression of specific marker genes [16]. 
Analizing differences in the poly(A)‘RNA patterns 
from nondifferentiated and differentiated F9 cells we 
found that out of 30 primers used, 8 primers identify at 
least 10 separate differentially expressed mRNAs. Prim- 
ers P35, P37, P43 and P55 revealed 4 individual bands 
(Fig. 2, bands 1, 3, 4, 5) induced at least 3-fold after 6 
days of differentiation. Primer F6 (band 2, 6 days of 
differentiation) provides an example of a small (less 
than 2-fold) change in mRNA content. Primers P36 and 
P48 did not reveal any differences. Table IB shows the 
results of sequencing the differentially represented 
bands 1, 3, 4. 5 and the bands 6, 7. 8 which did not 
change their level of expression. As in the case of fetal 
liver (Table IA, bands 9, 11, 12, 13) we found several 
examples of unclear sequencing (Table lB, bands 4, 6, 
7) and misincorporation (bands 1, 3). Searching for 
complementary mRNAs target sites in the GenBank 
database revealed that band 1 corresponds to mouse 
al-collagen type IV mRNA, band 3 to mouse T-com- 
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Table I 
Sequence of the mdividual bands and identification of RNAs in GenBank database 
Band 
No 
Sequence” of 
Primer-synth. cDNA (5’+3’) 
RNA(s) target site (3’+5’) 
Name of primer/RNA(s) GenBank database references 
(5’-end RNA target site position) 
A. Normal. cirrhotic and fetal livers (Fig. 1) 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
TGTGGCAGGgggt F6 
Numerous 6 mRNAs 
TGTGGCAGG:ggaacggct 
CGCCCGTCCTCCTTGCCGA - 
TGTmGGCAGGagacagcaccat 
ACAECGTCCTCTGTCGTGGTA - 
TGC'IGGCAGg:ggaacggct P41 
_XGCCCGTCCTCCTTGCCGA a2-globm 
TGCTGCCAGg~gacagcaccat 
ACAGCCGTCCTCTGTCGTGGTA - 
TGCTGGCAG.ggcagaggacaggt 
ACTACCGTCTCCGTCTCCTGTCCA 
TGCTGGCAGgggacagcaccdcggt P41 
None None 
TGCTGGCAGgggggygcagcgcaggggct P41 
None None 
'ECTGGTGGggat 
CCGACCACCCCTP. 
TGc?CGGTGGggaaggacaggaacat 
ACc:ACCACCCCTTCCTGTCCTTGTA - 
ECTGGTGGgcagagcgcgggcaggcgt 
GCGACCACCCGTCTCGCGCCCGTCCGCA - 
F6 
a3-globm 
F6 
z 1 -globm 
a2-globm 
P41 
CL 1 -globin 
P41 
G,-globin 
A,-globm 
P36 
Cytochrome P450 
Cystem protemase inhibitor 
P36 
a I -globm 
a3-globm 
HUMAGLI (837) 
HUMAGLI (137) 
HUMAGLI (837) 
HUMAGLl (137) 
HUMBGG (162) 
HUMHBGAB (444) 
HUMCYPC219 (1088) 
HUMINCP (1280) 
HUMGLl (350) 
P36 
Insulm-hke 
growth factor II 
HUMIGFlFP (269) 
B F9 Cell dtfferenttation (Fig. 2) 
TGCTGGGTGgggagcgcagagccccggcgt 
'XGACCCACGCCTCGCGTCTCGGGGCCGCA _ - 
TGCTGGCGGacagcct 
GCGACCGCCCGTCGGA - _ 
TGCTGACGGg:ggaacggct P37 
None None 
TGCTGACGGcat(agt)" P43 
GCGACTGCCGTA(TCA) Lammm A 
P36 
al (a2)-collagen 
type IV 
MUSCOL4A (403) 
P35 
T-complex testis 
expressed peptide 
MUSTCTEI (1465) 
TGCTGGCGGG::agacgggccggt P35 
CGCECGCCCXTCTGCCCGGCCA 28s rRNA 
MUSLASMARl (552) 
MUSRRM (1277) 
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Band 
No 
Sequence” of 
Primer-synth. cDNA (5’+3’) 
RNA(s) target site (3’t5’) 
Name of primer/RNA(s) GenBank database references 
(S-end RNA target site position) 
I TGCTGGCGGgJcggcgagacggcgt P35 
None None 
8 TGCTGACGGgcgagagggcggccccct P43 
TGCACTGCCCGCTCTCCCGCCGGGGGA 28s rRNA - MUSRRM (4554) 
“Upper case letters in the upper row show the seguence of the prtmer used. mismatched bases are printed m Italics and underlined. The synthesized 
cDNA sequence is printed m lower case letters. Uncertamties m sequencing arc marked by two bases at one position and underlined. 
bBrackets mark the sequence of band 5 after extension m the presence of 0.2 PM dTTP. 
plex associated testis-expressed peptide (Tctc 1) mRNA. 
band 5 to mouse laminin A mRNA, and bands 6 and 
8 to mouse 28s rRNA. The sequences of bands 4 and 
7 did not correspond to any complementary sites among 
genes/mRNAs accumulated in GenBank database. 
As the length of band 5 was too short (12 nucleotides) 
for searching complementary sequences in the GenBank 
database, we ‘extended’ this band by deliberately add- 
ing 0.2 PM of dTTP, in addition to ddUTP(SAA-Fam) 
and sequenced the band terminated at the second T, 
L 
11 - 
-- - -- 
--w 
d(T), 
sr 
c p36 PSS F6 P35 P37 P43 P4u 
DAYS 016 016 016 016 016 016 016 
Fig. 2. Changes m cDNA patterns synthesized by reverse transcriptase 
using poly(A)‘RNA from non-dtfferenttated (0) or F9 cells. treated 
with retmorc acid and dibutyryl CAMP for I day (1) or 6 days (6) using 
primers, P36, P55, F6. P35, P37. P43, P48. 
which was 3 nucleotides longer. This resulted in the 
finding of the laminin A mRNA sequence (Table lB, 
band 5). Among the detected differentially expressed 
mRNAs. mouse cll-collagen type IV mRNA and lam- 
inin A mRNA are well known markers of differentiated 
F9 cells [ 161 and Tctc 1 mRNA [ 171 is a new marker for 
F9 cell differentiation. 
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